Some types of non-Hodgkin lymphoma (NHL) are curable. Some people with other types are able to keep their disease under control and live good-quality lives with medical treatment.
Relative Survival Rate
Relative survival compares (1) how long a person with a disease survives after being diagnosed to (2) how long a person without the disease lives. Survival statistics for NHL are usually reported as five-year survival rates:
- The total averaged NHL five-year relative survival rates for 2002 to 2008 was 71 percent.
- An estimated 18,940 people will die from NHL in 2012.
- The five-year survival rate has risen from 31 percent in whites to 71 percent for persons of all races from 2002 to 2008.
Treatment results and outcomes vary among patients. It's important to understand that the latest five-year survival statistics only reflect rates up to 2008. Recent and ongoing improvements in treatment and care may not be reflected in these rates. Newer treatment therapies, progress in stem cell transplantation, better supportive care and studies of new drugs in clinical trials are all contributing to improved outcomes and quality of life for people diagnosed with blood cancers.
Source: SEER (Surveillance, Epidemiology and End Results) Cancer Statistics Review, 1975-2009, National Cancer Institute, 2012.